<p><b>A</b>. RAW 264.7 cells were pretreated with vehicle or 10 µM compound C (CC) for 15 min, prior to 1 µg/mL LPS challenge. After different time points of LPS challenge, expression of pAMPKα1 and pACC was determined by western blot. <b>B</b>. RAW 264.7 cells were treated with vehicle, 1 mM AICAR, 10 µM compound C (CC), or combination of AICAR and compound C for 15 min, followed by 1 µg/mL LPS treatment for 60 min. Expression of pAMPKα1 and pACC was determined by western blot. Data are represented three to four independent experiments.</p
<p>(A) H1993 cells were treated for 24 h with the indicated concentrations of YC and the protein exp...
<p>(A) Cells were pretreated with or without 10 µM genistein or 1 mM AICAR for 1 h and then incubate...
<p>A. Growth curve of 5-8F cells treated by LPS and LPLUNC1 transfection. LPS promoted NPC cell prol...
<p><b>A</b>. RAW 264.7 cells were treated with AICAR (1 mM) for different time points, and expressio...
<p>(A) Cells were treated with 1 mM AICAR for 60 min. p-AMPK (Thr172), p-TSC2 (Ser1387), and HIF-1α ...
<p>A–D, cells were treated and protein extracts were prepared and analyzed by Western blot. A–B, NCI...
<p><b>(A)</b> Western blot analysis of phospho-Thr172-AMPKα in shGTPBP3-1, shGTPBP3-2 and negative c...
<p>After serum starvation, cells were pre-treated with 25 μM Compound C for 1 h, followed by media r...
<p>Neuro2a cells were treated with AMPK inhibitor compound C (10 µM) for 1 h, followed by bupivacain...
<p><b>A & B</b>. phosphorylation of AMPK (Thr172) in HTOZ cells treated with norUDCA at 200 μM for i...
<p><b>A</b>, Immunoblot analysis of phosphorylated (pAMPK) and total AMPK levels in cells treated wi...
<p>Prostate cancer C4-2B and LNCaP cells were pre-treated with 20 µM of AMPK inhibitor Compound C (C...
<p>Cultured cells were treated for 60(control), LPS alone (100 ng/ml), or simultaneous LPS with SB20...
<p><i>A</i>, control and SCD1-deficient A549 cells were incubated with compound C (20 µM), AICAR (0....
<p>(A, B) Pam3CSK4 and LPS induce dose-dependent activation of PLK1. THP-1 cells were treated with t...
<p>(A) H1993 cells were treated for 24 h with the indicated concentrations of YC and the protein exp...
<p>(A) Cells were pretreated with or without 10 µM genistein or 1 mM AICAR for 1 h and then incubate...
<p>A. Growth curve of 5-8F cells treated by LPS and LPLUNC1 transfection. LPS promoted NPC cell prol...
<p><b>A</b>. RAW 264.7 cells were treated with AICAR (1 mM) for different time points, and expressio...
<p>(A) Cells were treated with 1 mM AICAR for 60 min. p-AMPK (Thr172), p-TSC2 (Ser1387), and HIF-1α ...
<p>A–D, cells were treated and protein extracts were prepared and analyzed by Western blot. A–B, NCI...
<p><b>(A)</b> Western blot analysis of phospho-Thr172-AMPKα in shGTPBP3-1, shGTPBP3-2 and negative c...
<p>After serum starvation, cells were pre-treated with 25 μM Compound C for 1 h, followed by media r...
<p>Neuro2a cells were treated with AMPK inhibitor compound C (10 µM) for 1 h, followed by bupivacain...
<p><b>A & B</b>. phosphorylation of AMPK (Thr172) in HTOZ cells treated with norUDCA at 200 μM for i...
<p><b>A</b>, Immunoblot analysis of phosphorylated (pAMPK) and total AMPK levels in cells treated wi...
<p>Prostate cancer C4-2B and LNCaP cells were pre-treated with 20 µM of AMPK inhibitor Compound C (C...
<p>Cultured cells were treated for 60(control), LPS alone (100 ng/ml), or simultaneous LPS with SB20...
<p><i>A</i>, control and SCD1-deficient A549 cells were incubated with compound C (20 µM), AICAR (0....
<p>(A, B) Pam3CSK4 and LPS induce dose-dependent activation of PLK1. THP-1 cells were treated with t...
<p>(A) H1993 cells were treated for 24 h with the indicated concentrations of YC and the protein exp...
<p>(A) Cells were pretreated with or without 10 µM genistein or 1 mM AICAR for 1 h and then incubate...
<p>A. Growth curve of 5-8F cells treated by LPS and LPLUNC1 transfection. LPS promoted NPC cell prol...